APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin (IVIg)

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Selected research

Industry Growth & Trends

Global Intravenous Immunoglobulin (IVIg) Industry Growth and Trends Forecast to 2032

Report ID 174004270121 December 2025104 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin (IVIg) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin (IVIg) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin (IVIg) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin (IVIg) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Intravenous Immunoglobulin (IVIg) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Immunoglobulin (IVIg) market size, estimates, and forecasts are presented in terms of sales volume (K Bottle) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Immunoglobulin (IVIg) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Immunoglobulin (IVIg).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Immunoglobulin (IVIg) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Immunoglobulin (IVIg) Market by Company

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Segment by Type

IVIg Liquid

IVIg Powder

Intravenous Immunoglobulin (IVIg) Segment by Application

Immunodeficiency

Autoimmune Disease

Acute Infection

Intravenous Immunoglobulin (IVIg) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IVIg Liquid Table 2. Major Company of IVIg Powder Table 3. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2021-2026) Table 8. Global Intravenous Immunoglobulin (IVIg) Price by Type (2021-2026) & (USD/Bottle) Table 9. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 10. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2027-2032) Table 13. Global Intravenous Immunoglobulin (IVIg) Price by Type (2027-2032) & (USD/Bottle) Table 14. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 15. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 17. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 19. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 21. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 23. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (US$ Million) Table 24. Intravenous Immunoglobulin (IVIg) Industry Trends Table 25. Intravenous Immunoglobulin (IVIg) Industry Drivers Table 26. Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges Table 27. Intravenous Immunoglobulin (IVIg) Industry Restraints Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2021-2026) Table 30. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2021-2026) & (K Bottle) Table 31. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2021-2026) Table 32. Global Intravenous Immunoglobulin (IVIg) Market Price by Company (2021-2026) & (USD/Bottle) Table 33. Global Intravenous Immunoglobulin (IVIg) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Intravenous Immunoglobulin (IVIg) Major Company Production Sites and Headquarters Table 35. Global Intravenous Immunoglobulin (IVIg) Company, Product Type & Application Table 36. Global Intravenous Immunoglobulin (IVIg) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Intravenous Immunoglobulin (IVIg) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle) Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Region (2021-2026) Table 44. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 45. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032) & (K Bottle) Table 46. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Region (2027-2032) Table 49. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2027-2032) Table 50. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 52. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2021-2026) Table 55. Global Intravenous Immunoglobulin (IVIg) Price by Application (2021-2026) & (USD/Bottle) Table 56. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 57. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2027-2032) Table 60. Global Intravenous Immunoglobulin (IVIg) Price by Application (2027-2032) & (USD/Bottle) Table 61. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 62. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 64. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 66. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 68. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 70. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (US$ Million) Table 71. Baxter Company Information Table 72. Baxter Business Overview Table 73. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 74. Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio Table 75. Baxter Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 79. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio Table 80. Grifols Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 84. CSL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 85. CSL Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 89. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio Table 90. Octapharma Recent Development Table 91. Biotest Company Information Table 92. Biotest Business Overview Table 93. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 94. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio Table 95. Biotest Recent Development Table 96. Kedrion Company Information Table 97. Kedrion Business Overview Table 98. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 99. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio Table 100. Kedrion Recent Development Table 101. Hualan Bio Company Information Table 102. Hualan Bio Business Overview Table 103. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 104. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio Table 105. Hualan Bio Recent Development Table 106. CNBG Company Information Table 107. CNBG Business Overview Table 108. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 109. CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio Table 110. CNBG Recent Development Table 111. Shanghai RAAS Company Information Table 112. Shanghai RAAS Business Overview Table 113. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 114. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio Table 115. Shanghai RAAS Recent Development Table 116. CBPO Company Information Table 117. CBPO Business Overview Table 118. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 119. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio Table 120. CBPO Recent Development Table 121. LFB Group Company Information Table 122. LFB Group Business Overview Table 123. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 124. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio Table 125. LFB Group Recent Development Table 126. BPL Company Information Table 127. BPL Business Overview Table 128. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 129. BPL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 130. BPL Recent Development Table 131. Sichuan Yuanda Shuyang Company Information Table 132. Sichuan Yuanda Shuyang Business Overview Table 133. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 134. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio Table 135. Sichuan Yuanda Shuyang Recent Development Table 136. North America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 137. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 138. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 139. North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle) Table 140. North America Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Country (2027-2032) Table 141. North America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Intravenous Immunoglobulin (IVIg) Market Share by Country (2021-2026) Table 144. North America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Intravenous Immunoglobulin (IVIg) Market Share Forecast by Country (2027-2032) Table 146. Europe Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 147. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 148. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 149. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle) Table 150. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Intravenous Immunoglobulin (IVIg) Market Share by Country (2021-2026) Table 154. Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Intravenous Immunoglobulin (IVIg) Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 158. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle) Table 160. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Share by Country (2021-2026) Table 164. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Share Forecast by Country (2027-2032) Table 166. Latin America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 167. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 168. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 169. Latin America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle) Table 170. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Intravenous Immunoglobulin (IVIg) Market Share by Country (2021-2026) Table 174. Latin America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Intravenous Immunoglobulin (IVIg) Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 178. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032) & (K Bottle) Table 180. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Share by Country (2021-2026) Table 184. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Intravenous Immunoglobulin (IVIg) Distributors List Table 189. Intravenous Immunoglobulin (IVIg) Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin (IVIg) Image Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Immunoglobulin (IVIg) Sales (2021-2032) & (K Bottle) Figure 5. IVIg Liquid Image Figure 6. Global IVIg Liquid Sales YoY Growth (2021-2032) & (K Bottle) Figure 7. IVIg Powder Image Figure 8. Global IVIg Powder Sales YoY Growth (2021-2032) & (K Bottle) Figure 9. Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Share by Type 2025 VS 2032 Figure 11. North America Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type in 2025 Figure 12. North America Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type in 2025 Figure 13. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Immunodeficiency Image Figure 24. Global Immunodeficiency Sales YoY Growth (2021-2032) & (K Bottle) Figure 25. Autoimmune Disease Image Figure 26. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (K Bottle) Figure 27. Acute Infection Image Figure 28. Global Acute Infection Sales YoY Growth (2021-2032) & (K Bottle) Figure 29. Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Intravenous Immunoglobulin (IVIg) Market Share by Application 2025 VS 2032 Figure 31. North America Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application in 2025 Figure 32. North America Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application in 2025 Figure 33. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application in 2025 Figure 41. North America Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 42. North America Intravenous Immunoglobulin (IVIg) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Intravenous Immunoglobulin (IVIg) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 46. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Intravenous Immunoglobulin (IVIg) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 50. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 54. Latin America Intravenous Immunoglobulin (IVIg) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Intravenous Immunoglobulin (IVIg) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 58. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Intravenous Immunoglobulin (IVIg) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Intravenous Immunoglobulin (IVIg) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
Companies covered
  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Immunoglobulin (IVIg) Market by Type
  6. 1.3.1 IVIg Liquid
  7. 1.3.2 IVIg Powder
  8. 1.4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
  9. 1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
  2. 2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
  3. 2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Immunoglobulin (IVIg) Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Immunoglobulin (IVIg) Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Immunoglobulin (IVIg) Price (2021-2026)
  4. 3.4 Global Intravenous Immunoglobulin (IVIg) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Immunoglobulin (IVIg) Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Immunoglobulin (IVIg) Company, Product Type & Application
  7. 3.7 Global Intravenous Immunoglobulin (IVIg) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier 3
4 Intravenous Immunoglobulin (IVIg) Regional Status and Outlook
  1. 4.1 Global Intravenous Immunoglobulin (IVIg) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size by Region
  3. 4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Immunoglobulin (IVIg) by Application
  1. 5.1 Intravenous Immunoglobulin (IVIg) Market by Application
  2. 5.1.1 Immunodeficiency
  3. 5.1.2 Autoimmune Disease
  4. 5.1.3 Acute Infection
  5. 5.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 5.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
  18. 6.3.5 CSL Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Biotest
  26. 6.5.1 Biotest Company Information
  27. 6.5.2 Biotest Business Overview
  28. 6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
  30. 6.5.5 Biotest Recent Developments
  31. 6.6 Kedrion
  32. 6.6.1 Kedrion Company Information
  33. 6.6.2 Kedrion Business Overview
  34. 6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
  36. 6.6.5 Kedrion Recent Developments
  37. 6.7 Hualan Bio
  38. 6.7.1 Hualan Bio Company Information
  39. 6.7.2 Hualan Bio Business Overview
  40. 6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
  42. 6.7.5 Hualan Bio Recent Developments
  43. 6.8 CNBG
  44. 6.8.1 CNBG Company Information
  45. 6.8.2 CNBG Business Overview
  46. 6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
  48. 6.8.5 CNBG Recent Developments
  49. 6.9 Shanghai RAAS
  50. 6.9.1 Shanghai RAAS Company Information
  51. 6.9.2 Shanghai RAAS Business Overview
  52. 6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
  54. 6.9.5 Shanghai RAAS Recent Developments
  55. 6.10 CBPO
  56. 6.10.1 CBPO Company Information
  57. 6.10.2 CBPO Business Overview
  58. 6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
  60. 6.10.5 CBPO Recent Developments
  61. 6.11 LFB Group
  62. 6.11.1 LFB Group Company Information
  63. 6.11.2 LFB Group Business Overview
  64. 6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
  66. 6.11.5 LFB Group Recent Developments
  67. 6.12 BPL
  68. 6.12.1 BPL Company Information
  69. 6.12.2 BPL Business Overview
  70. 6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
  72. 6.12.5 BPL Recent Developments
  73. 6.13 Sichuan Yuanda Shuyang
  74. 6.13.1 Sichuan Yuanda Shuyang Company Information
  75. 6.13.2 Sichuan Yuanda Shuyang Business Overview
  76. 6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
  78. 6.13.5 Sichuan Yuanda Shuyang Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
  2. 7.1.1 North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
  6. 7.2.1 North America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
  2. 8.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
  6. 8.2.1 Europe Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Immunoglobulin (IVIg) Sales by Country
  2. 10.1.1 South America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Immunoglobulin (IVIg) Market Size by Country
  6. 10.2.1 South America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
  2. 12.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Immunoglobulin (IVIg) Production Mode & Process
  7. 12.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Immunoglobulin (IVIg) Distributors
  10. 12.2.3 Intravenous Immunoglobulin (IVIg) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst